BioCentury | Sep 10, 2018
Company News

Management tracks: PolarityTE, Medivir

...disease company OxThera AB (Stockholm, Sweden) hired Hugo Petit as CFO. He was CFO of MedCap AB...
BioCentury | Jul 15, 2013
Company News

Medivir, MedCap AB deal

...Medivir sold its wholly owned subsidiary Cross Pharma AB to MedCap's Unimedic AB subsidiary for SEK125...
...& Co acted as legal advisors in the transaction. Medivir AB (SSE:MVIR B), Huddinge, Sweden MedCap AB...
BioCentury | Mar 31, 2008
Finance

Ebb & Flow

...for its rPA102 anthrax vaccine in December 2006. The week before the scheduled vote, investor MedCap...
...momentum for the transaction. At March 19, the firm held about 4.8% of VaxGen (NASDAQ:VXGN). MedCap...
BioCentury | Apr 25, 2005
Finance

Ebb & Flow

...radiotherapeutic to treat neuroendocrine tumors. Investors in the round included Siemens Venture Capital; Tudor Investment; MedCap...
BioCentury | Apr 22, 2005
Financial News

Molecular Insight raises $28 million

...led by Frederick Frank and Cerberus Capital. New investors included Siemens Venture Capital; Tudor Investment; MedCap...
Items per page:
1 - 5 of 5
BioCentury | Sep 10, 2018
Company News

Management tracks: PolarityTE, Medivir

...disease company OxThera AB (Stockholm, Sweden) hired Hugo Petit as CFO. He was CFO of MedCap AB...
BioCentury | Jul 15, 2013
Company News

Medivir, MedCap AB deal

...Medivir sold its wholly owned subsidiary Cross Pharma AB to MedCap's Unimedic AB subsidiary for SEK125...
...& Co acted as legal advisors in the transaction. Medivir AB (SSE:MVIR B), Huddinge, Sweden MedCap AB...
BioCentury | Mar 31, 2008
Finance

Ebb & Flow

...for its rPA102 anthrax vaccine in December 2006. The week before the scheduled vote, investor MedCap...
...momentum for the transaction. At March 19, the firm held about 4.8% of VaxGen (NASDAQ:VXGN). MedCap...
BioCentury | Apr 25, 2005
Finance

Ebb & Flow

...radiotherapeutic to treat neuroendocrine tumors. Investors in the round included Siemens Venture Capital; Tudor Investment; MedCap...
BioCentury | Apr 22, 2005
Financial News

Molecular Insight raises $28 million

...led by Frederick Frank and Cerberus Capital. New investors included Siemens Venture Capital; Tudor Investment; MedCap...
Items per page:
1 - 5 of 5